The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus
- PMID: 10391113
- DOI: 10.1007/s000110050456
The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease most prevalent in women between the ages of twenty and sixty. Successful treatment remains challenging due to a lack of understanding of the underlying mechanisms and multiple symptoms ranging from skin rashes to glomerulonephritis. The pathogenesis of SLE has been linked to a B-cell hyperproliferation unique to afflicted patients. These B-cells generate large quantities of IgG autoantibodies, ultimately capable of leading to lupus nephritis and renal failure. The significance of cytokines in SLE and in murine lupus, a related disease in mice, has been debated, particularly with respect to B-cell activity. Potential roles of auto-regulatory and inflammatory cytokines have been investigated. In particular, IL-6 and IL-10 have been shown to be key factors in regulating autoantibody-secreting B-cell activity in lupus. Here, we will provide a critical overview of our current knowledge of the regulatory roles of these two cytokines in SLE.
Similar articles
-
Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.J Exp Med. 1995 Mar 1;181(3):839-44. doi: 10.1084/jem.181.3.839. J Exp Med. 1995. PMID: 7869046 Free PMC article.
-
[Cytokines and lupus].Ann Med Interne (Paris). 1996;147(7):480-4. Ann Med Interne (Paris). 1996. PMID: 9092358 Review. French.
-
B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.J Rheumatol. 1993 Nov;20(11):1885-91. J Rheumatol. 1993. PMID: 7508509
-
Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?Lupus. 2009 Jun;18(7):575-80. doi: 10.1177/0961203309102296. Lupus. 2009. PMID: 19433456 Review.
-
Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.Immunology. 2006 Nov;119(3):296-305. doi: 10.1111/j.1365-2567.2006.02433.x. Immunology. 2006. PMID: 17067309 Free PMC article.
Cited by
-
Lupus patients with pulmonary involvement have a pro-inflammatory cytokines profile.Rheumatol Int. 2007 May;27(7):621-30. doi: 10.1007/s00296-006-0268-3. Epub 2006 Nov 14. Rheumatol Int. 2007. PMID: 17103171
-
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.Arthritis Res Ther. 2003;5(4):172-7. doi: 10.1186/ar770. Epub 2003 May 14. Arthritis Res Ther. 2003. PMID: 12823847 Free PMC article.
-
Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis.Clin Exp Immunol. 2009 Sep;157(3):350-8. doi: 10.1111/j.1365-2249.2009.03968.x. Clin Exp Immunol. 2009. PMID: 19664142 Free PMC article.
-
Circulating miR-21 Overexpression Correlates with PDCD4 and IL-10 in Systemic Lupus Erythematosus (SLE): A Promising Diagnostic and Prognostic Biomarker.Rep Biochem Mol Biol. 2023 Jul;12(2):220-232. doi: 10.61186/rbmb.12.2.220. Rep Biochem Mol Biol. 2023. PMID: 38317820 Free PMC article.
-
Stage dependent aberrant regulation of cytokine-STAT signaling in murine systemic lupus erythematosus.PLoS One. 2009 Aug 25;4(8):e6756. doi: 10.1371/journal.pone.0006756. PLoS One. 2009. PMID: 19707593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
